Cargando…
Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma
Introduction: Despite many recent emerging therapeutic modalities that have prolonged the survival of melanoma patients, the prognosis of melanoma remains discouraging, and further understanding of the mechanisms underlying melanoma progression is needed. Melanoma patients often have multiple geneti...
Autores principales: | Tao, Lei, Cui, Yingyue, Sun, Jiarui, Cao, Yu, Dai, Zhen, Ge, Xiaoming, Zhang, Ling, Ma, Run, Liu, Yunyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516578/ https://www.ncbi.nlm.nih.gov/pubmed/37745303 http://dx.doi.org/10.3389/fcell.2023.1171047 |
Ejemplares similares
-
BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer
por: Cen, Shuyi, et al.
Publicado: (2021) -
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
por: Vergani, Elisabetta, et al.
Publicado: (2022) -
Identification of Potential Biomarkers and Small Molecule Drugs for Cutaneous Melanoma Using Integrated Bioinformatic Analysis
por: Liu, Yong, et al.
Publicado: (2022) -
T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the BRAF(V600E) Mutation in Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2020) -
Extracellular vesicle DNA from human melanoma tissues contains cancer-specific mutations
por: Crescitelli, Rossella, et al.
Publicado: (2022)